TNFRSF4 and melanoma: In this context, in a mouse model of melanoma, the CD134 (OX40) and CD137 (4-1BB) costimulation as immunotherapy in the presence of IL-2, imprinted a cytotoxic phenotype relying on Eomesodermin, on both Ag-specific and bystander CD4+ Th1 cells (49).